Difesa Capital Management’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Difesa Capital Management’s Portfolio PEPLW Stock Details PEPLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-75,000	Closed	-$7.13K	–	128
2023 Q1	$7.13K	Hold	75,000	–	–	﹤0.01%	145
2022 Q4	$1.57K	Hold	75,000	–	–	﹤0.01%	210
2022 Q3	$6K	Hold	75,000	–	–	﹤0.01%	177
2022 Q2	$17K	Hold	75,000	–	–	0.01%	161
2022 Q1	$31K	Hold	75,000	–	–	0.02%	164
2021 Q4	$34K	Buy	+75,000	New	+$35.4K	0.02%	164

Other funds holding PEPLW

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

Difesa Capital Management's PEPLW Position: Q2 2023 in Review

Difesa Capital Management sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q2 2023, closing a stake of 75,000 shares — an estimated $7.13K sold.

Difesa Capital Management first reported a position in PEPLW in Q4 2021 and held it in 6 quarters. The position peaked at $34K in Q4 2021. 16 funds tracked by Wall St. Rank hold PEPLW as of Q2 2023.

Difesa Capital Management reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q2 2023 after selling out during the quarter.
Difesa Capital Management sold 75,000 PepperLime Health Acquisition Corporation Warrrant shares in Q2 2023, an estimated $7.13K.
Difesa Capital Management first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q4 2021 and held it in 6 quarters.
Difesa Capital Management's PepperLime Health Acquisition Corporation Warrrant position peaked at $34K in Q4 2021.
16 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q2 2023.

Based on Difesa Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.